Literature DB >> 6232854

The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.

R S Doggett, G S Wood, S Horning, R Levy, R F Dorfman, J Bindl, R A Warnke.   

Abstract

Ninety-five diffuse large cell lymphomas in 89 patients were stained in cryostat sections with a panel of monoclonal antibodies. Lymphoma cells from 47 patients (53%) expressed either kappa or lambda light chains, usually in combination with mu heavy chains. Fifteen samples from 12 patients (14%) expressed two or more T-cell antigens and commonly expressed Ia antigens. Lymphoma cells from 10 of these patients uniformly lacked one or more pan T-cell antigens; lymphoma cells from 4 of these patients also lacked both T-subset antigens--findings which should prove useful in diagnosis. Lymphomas from 28 patients (31%) did not express immunoglobulin or T-cell antigens but commonly expressed the B-lineage antigen B1; and the remaining 9 cases generally expressed Ia antigens, common ALL antigens, or both. Our findings confirm the marked immunologic heterogeneity of diffuse large cell lymphomas; the phenotypic heterogeneity observed in T-cell cases in many instances is difficult to reconcile with current models of T-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232854      PMCID: PMC1900485     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  Immunologic aspects and pathology of the malignant lymphomas.

Authors:  C W Berard; E S Jaffe; R C Braylan; R B Mann; K Nanba
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

2.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  A study of malignant lymphomas using light and ultramicroscopic, cytochemical and immunologic technics: correlation with clinical features.

Authors:  D A Filippa; P H Lieberman; R A Erlandson; B Koziner; F P Siegal; A Turnbull; A Zimring; R A Good
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

4.  A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.

Authors:  R J Lukes; C R Taylor; J W Parker; T L Lincoln; P K Pattengale; B H Tindle
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

5.  Advanced diffuse histiocytic lymphoma, a potentially curable disease.

Authors:  V T DeVita; G P Canellos; B Chabner; P Schein; S P Hubbard; R C Young
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

6.  Methods for decreasing interstitial immunoglobulin in tissue slices and cryostat sections.

Authors:  R A Warnke; J Bindl; R Doggett
Journal:  Histochem J       Date:  1983-07

7.  Stimulation by propylthiouracil of the hexose monophosphate shunt in human polymorphonuclear leucocytes during phagocytosis.

Authors:  M F Tsan; P A McIntyre
Journal:  Br J Haematol       Date:  1975-10       Impact factor: 6.998

8.  Membrane markers in "histiocytic" lymphomas (reticulum cell sarcomas).

Authors:  J C Brouet; J L Preud'Homme; G Flandrin; N Chelloul; M Seligmann
Journal:  J Natl Cancer Inst       Date:  1976-03       Impact factor: 13.506

9.  Clinical relevance of the histopathological subclassification of diffuse "histiocytic" lymphoma.

Authors:  J A Strauchen; R C Young; V T DeVita; T Anderson; J C Fantone; C W Berard
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

10.  Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.

Authors:  C D Bloomfield; J H Kersey; R D Brunning; K J Gajl-Peczalska
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

View more
  13 in total

Review 1.  Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.

Authors:  L J Picker; L M Weiss; L J Medeiros; G S Wood; R A Warnke
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

2.  Aberrant phenotypes in peripheral T cell lymphomas.

Authors:  N Hastrup; E Ralfkiaer; G Pallesen
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

3.  Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.

Authors:  L M Weiss; G S Crabtree; R V Rouse; R A Warnke
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

4.  Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.

Authors:  H J Schuurman; J van Baarlen; W Huppes; B W Lam; L F Verdonck; J A van Unnik
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

5.  Primary malignant lymphoma of the brain: an immunohistochemical study of eight cases using a panel of monoclonal and heterologous antibodies.

Authors:  T Kumanishi; K Washiyama; T Saito; A Nishiyama; S Abe; T Tanaka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  Primary malignant lymphoma of the brain: demonstration of immunoglobulin gene rearrangements in four cases by the Southern blot hybridization technique.

Authors:  T Kumanishi; K Washiyama; A Nishiyama; S Abe; T Saito; T Ichikawa
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Follicular large cell lymphoma. An immunophenotype study.

Authors:  C F Garcia; R A Warnke; L M Weiss
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

8.  Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique.

Authors:  R Namikawa; T Suchi; R Ueda; G Itoh; K Koike; K Ota; T Takahashi
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

9.  Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.

Authors:  L J Medeiros; A B Gelb; K Wolfson; R Doggett; B McGregor; R S Cox; S J Horning; R A Warnke
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

10.  Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics.

Authors:  G S Wood; R R Turner; R A Shiurba; L Eng; R A Warnke
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.